APA (7th ed.) Citation

Frigault, M. J., Bishop, M. R., Rosenblatt, J., O’Donnell, E. K., Raje, N., Cook, D., . . . Maus, M. V. (2023). Phase 1 study of CART-ddBCMA for the treatment of subjects with relapsed and refractory multiple myeloma. Blood advances, 7(5), 768-777. https://doi.org/10.1182/bloodadvances.2022007210

Chicago Style (17th ed.) Citation

Frigault, Matthew J., et al. "Phase 1 Study of CART-ddBCMA for the Treatment of Subjects with Relapsed and Refractory Multiple Myeloma." Blood Advances 7, no. 5 (2023): 768-777. https://doi.org/10.1182/bloodadvances.2022007210.

MLA (9th ed.) Citation

Frigault, Matthew J., et al. "Phase 1 Study of CART-ddBCMA for the Treatment of Subjects with Relapsed and Refractory Multiple Myeloma." Blood Advances, vol. 7, no. 5, 2023, pp. 768-777, https://doi.org/10.1182/bloodadvances.2022007210.